SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · PPR

Alternative Splicing Directs PMCA2 to Lysosomes and is Linked to Neurodegeneration

· 2025-10-02

DOI: 10.1101/2025.10.01.679724

Check source for accessPreprintOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Plasma membrane calcium ATPases (PMCAs) are believed to function exclusively at the plasma membrane where they expel calcium from the cytosol. We have unexpectedly identified a splice variant-dependent localisation of the PMCA isoform PMCA2 to the lysosome, where it forms an evolutionarily conserved complex with NPC1, the lysosomal membrane protein defective in the rare lysosomal storage disease Niemann-Pick disease type C (NPC). This interaction is required for lysosomal Ca 2+ homeostasis and implicates PMCA2 as a mediator of Ca 2+ uptake into lysosomes. Disruption of the NPC1-PMCA2 complex contributes to the pathophysiology of both Niemann-Pick disease type C and Parkinson’s disease, revealing an unrecognised intracellular function for PMCA2 and a shared mechanism linking lysosomal Ca 2+ and lipid regulation in neurodegeneration.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.